Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pharmacists and pharmaceutical manufacturers--adversaries or partners?

Stetler CJ.

J Am Pharm Assoc. 1976 Jul;16(7):403-5. No abstract available.

PMID:
950441
2.

Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?

Willig SH.

Spec Law Dig Health Care (Mon). 1987 Feb;8(12):7-40. No abstract available.

PMID:
10280590
3.
4.

The pharmacist and the doctor.

Mason R.

Nebr Med J. 1973 Jan;58(1):17-20. No abstract available.

PMID:
4682786
5.

ASHP guidelines for pharmacists on the activities of vendors' representatives in organized health care systems. American Society of Hospital Pharmacists.

Meyer GE, Keith TD, Gutfeld MB, Johnson D.

Am J Hosp Pharm. 1994 Feb 15;51(4):520-1. No abstract available.

PMID:
8017422
6.

Pharmaceuticals: Medicare Modernization Act.

Hilyard K, Howe WC.

Issue Brief Health Policy Track Serv. 2007 Jan 8:1-28. No abstract available.

PMID:
17361467
7.
8.

Editorial: The pharmacist and drug product selection.

Tice LF.

Am J Pharm Sci Support Public Health. 1974 May-Jun;146(3):67-9. No abstract available.

PMID:
4851580
9.

Major issues facing the pharmaceutical industry and their relationship to clinical pharmacy.

Riddiough MA.

Drug Intell Clin Pharm. 1984 Jan;18(1):59-61.

PMID:
6692740
10.

'Now it's their turn'.

Silverman M.

J Am Pharm Assoc. 1971 Jul;11(7):374-5 passim. No abstract available.

PMID:
5142131
11.

Pharmacists, pharmaceutical manufacturers, and conflicts of interest.

Banks D.

Am J Health Syst Pharm. 2005 Sep 1;62(17):1827-32. No abstract available.

PMID:
16120744
12.

Pharmacists' opinions about manufacturers' outreach programs.

Smith M, Basara L.

J Am Pharm Assoc (Wash). 1996 Aug;NS36(8):497-502. No abstract available.

PMID:
8783843
13.

Opportunities for pharmacists as managers: perceptions of senior executives in the pharmaceutical industry.

Walker SE, Schafermeyer KW, Rickert DR, Hurd PD.

J Am Pharm Assoc (Wash). 1999 Jan-Feb;39(1):41-4.

PMID:
9990186
14.

Women pharmacists in the pharmaceutical industry. Their preparation, satisfaction, and outlook.

Lear JS, Kirk KW.

Am Pharm. 1987 Jul;NS27(7):34-9. No abstract available.

PMID:
3630911
15.

[Research and pharmaceutical research workers].

Ferrari V.

Boll Chim Farm. 1971 Sep;110(9):483-91. Italian. No abstract available.

PMID:
5137985
16.
17.

Pharmacists want FDA to create new intermediate drug category.

Traynor K.

Am J Health Syst Pharm. 2008 Jan 1;65(1):10-4. No abstract available.

PMID:
18159029
18.

Challenging pharmaceutical industry political power in Maine and Vermont.

Castellblanch R.

J Health Polit Policy Law. 2003 Feb;28(1):109-32.

PMID:
12705419
19.

ASHP guidelines on pharmacists' relationships with industry.

[No authors listed]

Am J Hosp Pharm. 1992 Jan;49(1):154. No abstract available.

PMID:
1510758
20.

FDA aluminum rule poses challenges for industry, pharmacists.

Young D.

Am J Health Syst Pharm. 2004 Apr 15;61(8):742, 744. No abstract available.

PMID:
15127953

Supplemental Content

Support Center